BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19390420)

  • 1. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney.
    Osunkoya AO; Young AN; Wang W; Netto GJ; Epstein JI
    Am J Surg Pathol; 2009 Jul; 33(7):1103-6. PubMed ID: 19390420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
    Amin MB; MacLennan GT; Gupta R; Grignon D; Paraf F; Vieillefond A; Paner GP; Stovsky M; Young AN; Srigley JR; Cheville JC
    Am J Surg Pathol; 2009 Mar; 33(3):384-92. PubMed ID: 19011562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
    Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
    Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
    Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
    Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
    Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
    Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
    Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis.
    Al-Hussain TO; Cheng L; Zhang S; Epstein JI
    Hum Pathol; 2013 Jul; 44(7):1406-11. PubMed ID: 23427871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.
    MacLennan GT; Farrow GM; Bostwick DG
    Urology; 1997 Nov; 50(5):679-84. PubMed ID: 9372874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.
    Vilà MR; Nicolás A; Morote J; de I; Meseguer A
    Cancer; 2000 Jul; 89(1):152-64. PubMed ID: 10897012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization.
    Haller F; Kulle B; Schwager S; Gunawan B; von Heydebreck A; Sültmann H; Füzesi L
    Anal Biochem; 2004 Dec; 335(1):1-9. PubMed ID: 15519565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.